Published : Nov-2020
No. of Pages : 318
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Lung Cancer Overview
3 Products under Development
3.1 Lung Cancer - Pipeline Products by Stage of Development
3.2 Lung Cancer - Pipeline Products by Territory
3.3 Lung Cancer - Pipeline Products by Regulatory Path
3.4 Lung Cancer - Pipeline Products by Estimated Approval Date
3.5 Lung Cancer - Ongoing Clinical Trials
4 Lung Cancer - Pipeline Products under Development by Companies
4.1 Lung Cancer Companies - Pipeline Products by Stage of Development
4.2 Lung Cancer - Pipeline Products by Stage of Development
5 Lung Cancer Companies and Product Overview
6 Lung Cancer- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Table 1: Lung Cancer - Pipeline Products by Stage of Development
Table 2: Lung Cancer - Pipeline Products by Territory
Table 3: Lung Cancer - Pipeline Products by Regulatory Path
Table 4: Lung Cancer - Pipeline Products by Estimated Approval Date
Table 5: Lung Cancer - Ongoing Clinical Trials
Table 6: Lung Cancer Companies - Pipeline Products by Stage of Development
Table 7: Lung Cancer - Pipeline Products by Stage of Development
Table 8: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Onco 88 - Lung Cancer - Product Status
Table 10: Onco 88 - Lung Cancer - Product Description
Table 11: OncoStain 88 - Lung Cancer - Product Status
Table 12: OncoStain 88 - Lung Cancer - Product Description
Table 13: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 14: Alinity i Assay - NSE - Product Status
Table 15: Alinity i Assay - NSE - Product Description
Table 16: ARCHITECT c4000 System - NSE Assay - Product Status
Table 17: ARCHITECT c4000 System - NSE Assay - Product Description
Table 18: ARCHITECT c8000 System - NSE Assay - Product Status
Table 19: ARCHITECT c8000 System - NSE Assay - Product Description
Table 20: ARCHITECT ci4100 Integrated System - NSE Assay - Product Status
Table 21: ARCHITECT ci4100 Integrated System - NSE Assay - Product Description
Table 22: ARCHITECT ci8200 Integrated System - NSE Assay - Product Status
Table 23: ARCHITECT ci8200 Integrated System - NSE Assay - Product Description
Table 24: ARCHITECT i1000SR System - NSE Assay - Product Status
Table 25: ARCHITECT i1000SR System - NSE Assay - Product Description
Table 26: ARCHITECT i2000SR System - Neuron-Specific Enolase Assay - Product Status
Table 27: ARCHITECT i2000SR System - Neuron-Specific Enolase Assay - Product Description
Table 28: PRAME Antigen Lung Cancer Assay - Product Status
Table 29: PRAME Antigen Lung Cancer Assay - Product Description
Table 30: Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 31: Diagnostic Assay - Lung Cancer - Product Status
Table 32: Diagnostic Assay - Lung Cancer - Product Description
Table 33: MCM Test - Lung Cancer - Product Status
Table 34: MCM Test - Lung Cancer - Product Description
Table 35: Aberystwyth University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Diagnostic Biomarker Test - Lung Cancer - Product Status
Table 37: Diagnostic Biomarker Test - Lung Cancer - Product Description
Table 38: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Diagnostic Test - ACTN4 - Product Status
Table 40: Diagnostic Test - ACTN4 - Product Description
Table 41: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Companion Diagnostic Test - Lung Cancer - Product Status
Table 43: Companion Diagnostic Test - Lung Cancer - Product Description
Table 44: Diagnostic/Prognostic Assay - Lung Cancer - Product Status
Table 45: Diagnostic/Prognostic Assay - Lung Cancer - Product Description
Table 46: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 47: DiagnoLung - Product Status
Table 48: DiagnoLung - Product Description
Table 49: Predictive Diagnostic Test - Lung Cancer - Product Status
Table 50: Predictive Diagnostic Test - Lung Cancer - Product Description
Table 51: Prognostic Test - Lung Cancer - Product Status
Table 52: Prognostic Test - Lung Cancer - Product Description
Table 53: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 54: Biomarker Assay - Lung Cancer - Product Status
List of Figures
Figure 1: Lung Cancer - Pipeline Products by Stage of Development
Figure 2: Lung Cancer - Pipeline Products by Territory
Figure 3: Lung Cancer - Pipeline Products by Regulatory Path
Figure 4: Lung Cancer - Pipeline Products by Estimated Approval Date
Figure 5: Lung Cancer - Ongoing Clinical Trials
